Ringer lactate similar to standard salt solution

Article

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

Ringer lactate similar to standard salt solution

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

A team led by Dr Barun K. Nayak, Hinduja Hospital, Veer Sawarkar Marg, Mahim, Mumbai, India, conducted a prospective randomized controlled double-blinded clinical study on 75 eyes of 75 patients with senile cataract up to nuclear grade III. All patients were randomized to receive a fortified balanced salt solution (Group A) or Ringer lactate (Group B) as an intraocular irrigating solution.

Corneal endothelial cell density was the primary outcome and pachymetry was recorded preoperatively and one week and one and six months after treatment.

The results revealed no significant difference in postoperative percentage of endothelial cell loss between the two groups at one week, one month and 6 month follow-ups.

Postoperative percentage change in pachymetry was not significant between the two groups at the one week or one month follow-ups but there was a significant difference at the six-month follow-up.

The abstract was published in the Journal of Cataract and Refractive Surgery .

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.